Skip to main content
Caplight Logo









Twogee Biotech

Twogee Biotech

Private
GermanyHealthcare & Life Scienceshttps://www.twogee-biotech.com/

Last Round

Seed

Jan 29, 2026

Total Funding Raised

$2.59M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Twogee Biotech is a biotechnology company that develops customized enzyme solutions and production strains for the industrial conversion of biomass into sustainable raw materials.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Circular Economy, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

industrial biotechnologyenzyme engineeringstrain engineeringbiomass valorizationwhite biotechbioprocess integrationfermentation technologyenzyme cocktailssynthetic biologysynbiobiomanufacturingtechnology transfercustom R&Dcircular economysustainable materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Twogee Biotech Comparables

Compare Twogee Biotech with similar companies based on industry and business-model similarity.

Twogee Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
JunkemBio
67%
SeSaM-Biotech GmbH
62%
Ginkgo Bioworks
61%

Twogee Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 29, 2026

Key People

Founding team and executive leadership

Frank Wallrapp

CEO & Co-Founder

Founding Team

Sabrina Albig

Chief Operating Officer

Executive Team

Twogee Biotech Investors

Notable investors and investment history

Twogee Biotech investors
InvestorRounds
AgriFoodTech Venture AllianceSeed
Bayern KapitalSeed
High-Tech GründerfondsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 23, 2026

    Added EIT Food, a Food & Beverage Innovation company, as a customer.

  • May 23, 2026

    Added Chemie-Cluster Bayern GmbH as a customer.

Twogee Biotech Filings

Explore SEC and related filing metadata, where available.

Twogee Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Twogee Biotech's valuation, stock price, and market status.

Is Twogee Biotech a public or private company?

Twogee Biotech is a private company.

What is the current stock price of Twogee Biotech?

Twogee Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Twogee Biotech worth (valuation)?

Valuation information for Twogee Biotech is not publicly available.

Can I buy Twogee Biotech stock?

Twogee Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Twogee Biotech's last funding round?

Twogee Biotech's most recent funding round was Seed on January 29, 2026.

Who are the main investors in Twogee Biotech?

Key investors in Twogee Biotech include Bayern Kapital, High-Tech Gründerfonds.

Will Twogee Biotech IPO soon?

No public IPO plans have been announced for Twogee Biotech.

How can I track Twogee Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Twogee Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGermany
Employee Range5
Year Founded2024
Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?